Pinkerton Joann V, Conner Edward A, Kaunitz Andrew M
Department of Obstetrics and Gynecology, Division of Midlife Health, University of Virginia Health System, Charlottesville, Virginia.
University of Florida College of Medicine-Jacksonville, Jacksonville, Florida.
Clin Obstet Gynecol. 2019 Dec;62(4):677-686. doi: 10.1097/GRF.0000000000000487.
Hormone therapy remains the most effective treatment for menopausal symptoms but decisions are complex, requiring an assessment of benefits and risks and determination of best treatment type, dose, and duration. Benefits exceed risks for most women with bothersome menopausal symptoms or high risk for fracture if initiated under age 60 years or within 10 years since menopause. Long-term mortality and safety data from the Women's Health Initiative is reassuring, with no increase in deaths from cardiovascular disease or cancer compared with placebo after 18 years of follow-up and a trend towards less mortality in those who initiate hormone therapy ages 50 to 59 years.